
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1B | $1.1B | $1.2B | $917M | $824.2M | |
Revenue Growth (YoY) | -21.95% | 0.36% | 7.99% | -23.74% | -10.12% | |
Cost of Revenues | $439.7M | $408M | $422M | $338.7M | $286.9M | |
Gross Profit | $669.7M | $705.3M | $780.4M | $578.2M | $537.2M | |
Gross Profit Margin | 60.36% | 63.35% | 64.9% | 63.06% | 65.19% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $492.8M | $511.7M | $578.8M | $509.4M | $487.4M | |
Other Inc / (Exp) | -$67.1M | $7.1M | -$42.2M | -$267.6M | -$69M | |
Operating Expenses | $492.8M | $511.7M | $578.8M | $509.4M | $487.4M | |
Operating Income | $176.9M | $193.6M | $201.5M | $68.8M | $49.8M | |
Net Interest Expenses | $68.5M | $66.4M | $60.4M | $61.7M | $46.8M | |
EBT. Incl. Unusual Items | $41.2M | $134.3M | $99M | -$260.5M | -$66M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$108M | $32.7M | $44.6M | -$1.2M | $8.2M | |
Net Income to Company | $149.2M | $101.6M | $54.3M | -$259.3M | -$74.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $149.2M | $101.6M | $54.3M | -$259.3M | -$74.2M | |
Basic EPS (Cont. Ops) | $4.73 | $3.02 | $1.58 | -$7.47 | -$2.00 | |
Diluted EPS (Cont. Ops) | $4.42 | $2.78 | $1.49 | -$7.47 | -$2.00 | |
Weighted Average Basic Share | $31.5M | $33.6M | $34.3M | $34.7M | $37.1M | |
Weighted Average Diluted Share | $33.8M | $36.5M | $36.5M | $34.7M | $37.1M | |
EBITDA | $256.3M | $306.2M | $247.8M | -$135.6M | $33.6M | |
EBIT | $109.8M | $200.7M | $159.4M | -$198.8M | -$19.2M | |
Revenue (Reported) | $1.1B | $1.1B | $1.2B | $917M | $824.2M | |
Operating Income (Reported) | $176.9M | $193.6M | $201.5M | $68.8M | $49.8M | |
Operating Income (Adjusted) | $109.8M | $200.7M | $159.4M | -$198.8M | -$19.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $280.6M | $308.4M | $245.6M | $233.6M | $181.4M | |
Revenue Growth (YoY) | -11.92% | 9.9% | -20.37% | -4.86% | -22.37% | |
Cost of Revenues | $98.2M | $110.5M | $90.7M | $80M | $62.1M | |
Gross Profit | $182.4M | $197.9M | $154.8M | $153.6M | $119.3M | |
Gross Profit Margin | 65.02% | 64.16% | 63.04% | 65.76% | 65.77% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $117.8M | $146.1M | $124M | $122.5M | $122.3M | |
Other Inc / (Exp) | -$640K | $6.3M | -$487K | -$4M | -$376K | |
Operating Expenses | $117.8M | $146.1M | $124M | $122.5M | $122.3M | |
Operating Income | $64.6M | $51.7M | $30.8M | $31.1M | -$3M | |
Net Interest Expenses | $15.7M | $14.9M | $16.5M | $13.4M | $9.1M | |
EBT. Incl. Unusual Items | $48.3M | $43.1M | $13.8M | $13.8M | -$12.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $11.8M | $9.6M | $4.5M | $5.4M | -$2.9M | |
Net Income to Company | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Basic EPS (Cont. Ops) | $1.10 | $0.98 | $0.27 | $0.24 | -$0.22 | |
Diluted EPS (Cont. Ops) | $1.07 | $0.88 | $0.25 | $0.22 | -$0.22 | |
Weighted Average Basic Share | $33.1M | $34.2M | $34.6M | $35.2M | $43.4M | |
Weighted Average Diluted Share | $34M | $38M | $37M | $38M | $43.4M | |
EBITDA | $83.7M | $80M | $45.7M | $41.7M | $8.1M | |
EBIT | $64M | $58M | $30.3M | $27.2M | -$3.4M | |
Revenue (Reported) | $280.6M | $308.4M | $245.6M | $233.6M | $181.4M | |
Operating Income (Reported) | $64.6M | $51.7M | $30.8M | $31.1M | -$3M | |
Operating Income (Adjusted) | $64M | $58M | $30.3M | $27.2M | -$3.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1B | $1.1B | $1.1B | $905M | $771.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $419.9M | $420.4M | $402.2M | $328M | $269M | |
Gross Profit | $651.5M | $720.7M | $737.3M | $577.1M | $502.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $471.7M | $540M | $556.7M | $507.9M | $487.3M | |
Other Inc / (Exp) | -$67.5M | $14M | -$48.9M | -$271.1M | -$65.4M | |
Operating Expenses | $471.7M | $540M | $556.7M | $507.9M | $487.3M | |
Operating Income | $179.8M | $180.7M | $180.6M | $69.2M | $15.6M | |
Net Interest Expenses | $64.3M | $65.6M | $62M | $58.6M | $42.5M | |
EBT. Incl. Unusual Items | $48M | $129.1M | $69.7M | -$260.5M | -$92.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$109.6M | $30.5M | $39.5M | -$348K | -$44K | |
Net Income to Company | $157.6M | $98.6M | $30.2M | -$260.2M | -$92.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $157.6M | $98.6M | $30.2M | -$260.2M | -$92.3M | |
Basic EPS (Cont. Ops) | $4.98 | $2.90 | $0.88 | -$7.47 | -$2.53 | |
Diluted EPS (Cont. Ops) | $4.72 | $2.62 | $0.76 | -$7.52 | -$2.53 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $240.7M | $302.4M | $213.5M | -$139.6M | -$65K | |
EBIT | $112.3M | $194.7M | $131.7M | -$201.9M | -$49.8M | |
Revenue (Reported) | $1.1B | $1.1B | $1.1B | $905M | $771.9M | |
Operating Income (Reported) | $179.8M | $180.7M | $180.6M | $69.2M | $15.6M | |
Operating Income (Adjusted) | $112.3M | $194.7M | $131.7M | -$201.9M | -$49.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $280.6M | $308.4M | $245.6M | $233.6M | $181.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $98.2M | $110.5M | $90.7M | $80M | $62.1M | |
Gross Profit | $182.4M | $197.9M | $154.8M | $153.6M | $119.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $117.8M | $146.1M | $124M | $122.5M | $122.3M | |
Other Inc / (Exp) | -$640K | $6.3M | -$487K | -$4M | -$376K | |
Operating Expenses | $117.8M | $146.1M | $124M | $122.5M | $122.3M | |
Operating Income | $64.6M | $51.7M | $30.8M | $31.1M | -$3M | |
Net Interest Expenses | $15.7M | $14.9M | $16.5M | $13.4M | $9.1M | |
EBT. Incl. Unusual Items | $48.3M | $43.1M | $13.8M | $13.8M | -$12.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $11.8M | $9.6M | $4.5M | $5.4M | -$2.9M | |
Net Income to Company | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Basic EPS (Cont. Ops) | $1.10 | $0.98 | $0.27 | $0.24 | -$0.22 | |
Diluted EPS (Cont. Ops) | $1.07 | $0.88 | $0.25 | $0.22 | -$0.22 | |
Weighted Average Basic Share | $33.1M | $34.2M | $34.6M | $35.2M | $43.4M | |
Weighted Average Diluted Share | $34M | $38M | $37M | $38M | $43.4M | |
EBITDA | $83.7M | $80M | $45.7M | $41.7M | $8.1M | |
EBIT | $64M | $58M | $30.3M | $27.2M | -$3.4M | |
Revenue (Reported) | $280.6M | $308.4M | $245.6M | $233.6M | $181.4M | |
Operating Income (Reported) | $64.6M | $51.7M | $30.8M | $31.1M | -$3M | |
Operating Income (Adjusted) | $64M | $58M | $30.3M | $27.2M | -$3.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.4M | $11.3M | $16M | $18.2M | $16.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $296.6M | $279.1M | $284.7M | $205.5M | $161.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $13.4M | $22.4M | $25.1M | $17.8M | $13.9M | |
Other Current Assets | $37.1M | $37.9M | $28.8M | $2.7M | $2.1M | |
Total Current Assets | $369.7M | $370.6M | $378.3M | $266.9M | $210.7M | |
Property Plant And Equipment | $89M | $50.9M | $42.3M | $38.6M | $44.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $609.5M | $671.9M | $566M | $302.4M | $253.3M | |
Other Intangibles | $31.8M | $82.6M | $34.7M | $18.8M | $34.3M | |
Other Long-Term Assets | $21.9M | $33.9M | $42.6M | $28.5M | $25.9M | |
Total Assets | $1.2B | $1.3B | $1.2B | $783.2M | $712.2M | |
Accounts Payable | $8.9M | $8.6M | $19M | $10.3M | $13M | |
Accrued Expenses | $111.1M | $112.4M | $117M | $97.1M | $90.7M | |
Current Portion Of Long-Term Debt | -- | $70M | $70M | $70M | $13.1M | |
Current Portion Of Capital Lease Obligations | -- | $11.8M | -- | -- | -- | |
Other Current Liabilities | $9.9M | $3.4M | $42.9M | $32.4M | $34.3M | |
Total Current Liabilities | $207.4M | $307.1M | $300.5M | $263.2M | $196.3M | |
Long-Term Debt | $528.4M | $492.5M | $399.8M | $278.9M | $271.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $985.8M | $795.6M | $630.5M | $515.2M | |
Common Stock | $596K | $608K | $613K | $627K | $706K | |
Other Common Equity Adj | -- | -$8M | -$16.3M | -$15.2M | -$14.9M | |
Common Equity | $196.8M | $314.7M | $382.3M | $152.7M | $196.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $196.8M | $314.7M | $382.3M | $152.7M | $196.9M | |
Total Liabilities and Equity | $1.2B | $1.3B | $1.2B | $783.2M | $712.2M | |
Cash and Short Terms | $2.4M | $11.3M | $16M | $18.2M | $16.3M | |
Total Debt | $528.4M | $562.5M | $469.8M | $348.9M | $284.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $29.8M | $21.4M | $15.4M | $14.4M | $11M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $354.7M | $305.7M | $271.9M | $204.1M | $139.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $36.3M | $43.1M | $39.6M | $31.6M | $30.8M | |
Other Current Assets | $24.3M | $39.3M | $51.7M | $2.4M | $2M | |
Total Current Assets | $463.6M | $428.9M | $388.6M | $275M | $202.7M | |
Property Plant And Equipment | $123.3M | $50M | $38.1M | $37.8M | $42M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $679.6M | $673.7M | $564.9M | $299.6M | $253.8M | |
Other Intangibles | $145.6M | $77.5M | $33M | $11.6M | $32M | |
Other Long-Term Assets | $34.4M | $30.8M | $31.8M | $31.4M | $26.8M | |
Total Assets | $1.5B | $1.4B | $1.2B | $786.8M | $703.7M | |
Accounts Payable | $20M | $16.4M | $9M | $19.7M | $5.9M | |
Accrued Expenses | $119.9M | $121.5M | $114.8M | $77M | $77.2M | |
Current Portion Of Long-Term Debt | $70M | $70M | $70M | $52.5M | $26.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $20.3M | $48.3M | $10.2M | $8M | $6.8M | |
Total Current Liabilities | $346.2M | $342.5M | $296.8M | $239.7M | $189.4M | |
Long-Term Debt | $650.2M | $499.3M | $383.7M | $295.1M | $272.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1B | $777.2M | $619.8M | $510.5M | |
Common Stock | $598K | $609K | $616K | $633K | $715K | |
Other Common Equity Adj | -$3M | -$2.6M | -$18.4M | -$15.5M | -$15.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $229.2M | $356.4M | $395.1M | $167.1M | $193.2M | |
Total Liabilities and Equity | $1.5B | $1.4B | $1.2B | $786.8M | $703.7M | |
Cash and Short Terms | $29.8M | $21.4M | $15.4M | $14.4M | $11M | |
Total Debt | $720.2M | $569.3M | $453.7M | $347.6M | $299M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $149.2M | $101.6M | $54.3M | -$259.3M | -$74.2M | |
Depreciation & Amoritzation | $146.5M | $105.5M | $88.4M | $63.3M | $52.8M | |
Stock-Based Compensation | -$2.9M | $8.1M | $14.6M | $22.2M | $24.1M | |
Change in Accounts Receivable | $41.8M | $80M | -$2.5M | $54M | $23.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $232.8M | $170.6M | $148.6M | $148.2M | $89.8M | |
Capital Expenditures | $27.8M | $26.8M | $29.2M | $33.4M | $33.5M | |
Cash Acquisitions | -- | -$175.4M | -$22.8M | -$8.9M | -$76.9M | |
Cash From Investing | -$26.2M | -$196.6M | -$52M | -$42.5M | -$110.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | $1.7B | $976.3M | $920M | $672.7M | |
Long-Term Debt Repaid | -$1.3B | -$1.7B | -$1.1B | -$1B | -$742.1M | |
Repurchase of Common Stock | -$30.6M | -- | -- | -- | -$499K | |
Other Financing Activities | -$580K | -$6.9M | $6.7M | $6.3M | $1.7M | |
Cash From Financing | -$206.1M | $39.1M | -$91.1M | -$103.5M | $19.2M | |
Beginning Cash (CF) | $1.9M | $2.4M | $13.6M | $18.2M | $20.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $494K | $13.1M | $5.5M | $2.2M | -$1.4M | |
Ending Cash (CF) | $2.4M | $13.6M | $18.2M | $20.5M | $17.8M | |
Levered Free Cash Flow | $205M | $143.7M | $119.3M | $114.8M | $56.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Depreciation & Amoritzation | $19.7M | $22M | $15.4M | $14.6M | $11.5M | |
Stock-Based Compensation | $2M | $1.9M | $5.4M | $5.3M | $7.7M | |
Change in Accounts Receivable | $28.3M | -$11.1M | $16.7M | -$11.4M | $17M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $14.2M | $29.3M | $32.3M | $5.4M | -$10.5M | |
Capital Expenditures | $3.7M | $4M | $5.1M | $7.3M | $7.1M | |
Cash Acquisitions | -$174.2M | -$22M | -- | -- | -$143K | |
Cash From Investing | -$177.9M | -$26M | -$5.1M | -$7.3M | -$7.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $928.9M | $302.4M | $272.9M | $205.4M | $109.6M | |
Long-Term Debt Repaid | -$735.1M | -$296.8M | -$290.2M | -$207.8M | -$95.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.6M | $839K | $267K | $918K | -$1.6M | |
Cash From Financing | $191.8M | $6.4M | -$17.1M | -$1.6M | $12.3M | |
Beginning Cash (CF) | $2.4M | $13.6M | $18.2M | $20.5M | $17.8M | |
Foreign Exchange Rate Adjustment | -$707K | $541K | -$290K | -$723K | $124K | |
Additions / Reductions | $28.1M | $9.7M | $10.1M | -$3.4M | -$5.4M | |
Ending Cash (CF) | $29.8M | $23.8M | $28M | $16.4M | $12.5M | |
Levered Free Cash Flow | $10.5M | $25.3M | $27.2M | -$1.8M | -$17.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $157.6M | $98.6M | $30.2M | -$260.2M | -$92.3M | |
Depreciation & Amoritzation | $128.4M | $107.7M | $81.9M | $62.4M | $49.8M | |
Stock-Based Compensation | $5.1M | $8.1M | $18.1M | $22.1M | $26.6M | |
Change in Accounts Receivable | $79.5M | $40.6M | $25.3M | $25.8M | $52.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $201.3M | $185.7M | $151.6M | $121.4M | $73.9M | |
Capital Expenditures | $22.3M | $27.2M | $30.4M | $35.5M | $33.3M | |
Cash Acquisitions | -$174.2M | -$23.2M | -$790K | -$8.9M | -$77M | |
Cash From Investing | -$196.4M | -$44.7M | -$31.2M | -$44.7M | -$110.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.7B | $1.1B | $946.8M | $852.5M | $577M | |
Long-Term Debt Repaid | -$1.7B | -$1.3B | -$1.1B | -$963.3M | -$630M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.1M | -$2.5M | $6.2M | $7M | -$854K | |
Cash From Financing | $24.5M | -$146.3M | -$114.5M | -$88M | $33.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $29.3M | -$5.3M | $5.9M | -$11.3M | -$3.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $179M | $158.5M | $121.2M | $85.8M | $40.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $36.5M | $33.5M | $9.3M | $8.4M | -$9.6M | |
Depreciation & Amoritzation | $19.7M | $22M | $15.4M | $14.6M | $11.5M | |
Stock-Based Compensation | $2M | $1.9M | $5.4M | $5.3M | $7.7M | |
Change in Accounts Receivable | $28.3M | -$11.1M | $16.7M | -$11.4M | $17M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $14.2M | $29.3M | $32.3M | $5.4M | -$10.5M | |
Capital Expenditures | $3.7M | $4M | $5.1M | $7.3M | $7.1M | |
Cash Acquisitions | -$174.2M | -$22M | -- | -- | -$143K | |
Cash From Investing | -$177.9M | -$26M | -$5.1M | -$7.3M | -$7.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $928.9M | $302.4M | $272.9M | $205.4M | $109.6M | |
Long-Term Debt Repaid | -$735.1M | -$296.8M | -$290.2M | -$207.8M | -$95.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.6M | $839K | $267K | $918K | -$1.6M | |
Cash From Financing | $191.8M | $6.4M | -$17.1M | -$1.6M | $12.3M | |
Beginning Cash (CF) | $2.4M | $13.6M | $18.2M | $20.5M | $17.8M | |
Foreign Exchange Rate Adjustment | -$707K | $541K | -$290K | -$723K | $124K | |
Additions / Reductions | $28.1M | $9.7M | $10.1M | -$3.4M | -$5.4M | |
Ending Cash (CF) | $29.8M | $23.8M | $28M | $16.4M | $12.5M | |
Levered Free Cash Flow | $10.5M | $25.3M | $27.2M | -$1.8M | -$17.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.